• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Solventum Corp (SOLV)

Ordinary Shares
Sell: $72.00|Buy: $75.74|Change: 0.49 (-0.66%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.

Address




Website

https://www.solventum.com/en-us/home

Sector 

Healthcare

Forecast key dates

NameKey Date
Solventum Corp First Quarter Earnings Conference Call for 20262026-05-08T16:30:00
Solventum Corp First Quarter Earnings Results for 20262026-05-08T00:00:00
Solventum Corp Annual General Meeting for 20252026-04-30T00:00:00
Solventum Corp Fourth Quarter Earnings Conference Call for 20252026-02-27T15:30:00
Solventum Corp Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
Solventum Corp Annual Report for 20252026-02-27T00:00:00
Solventum Corp Third Quarter Earnings Conference Call for 20252025-11-07T16:30:00
Solventum Corp Third Quarter Earnings Results for 20252025-11-07T00:00:00
Solventum Corp Second Quarter Earnings Conference Call for 20252025-08-08T16:30:00
Solventum Corp Second Quarter Earnings Results for 20252025-08-08T00:00:00
Goldman Sachs 46th Annual Global Health Care Conference2025-06-10T16:00:00

Previous key dates

NameKey Date
Goldman Sachs 46th Annual Global Health Care Conference2025-06-10T16:00:00
2025 BofA Securities Health Care Conference2025-05-13T14:20:00
Solventum Corp First Quarter Earnings Conference Call for 20252025-05-08T16:30:00
Solventum Corp First Quarter Earnings Result for 20252025-05-08T00:00:00
Solventum Corp Annual General Meeting for 20242025-04-30T00:00:00
Solventum Corp Annual Report for 20242025-02-28T00:00:00
Solventum Corp Fourth Quarter Earnings Conference Call for 20242025-02-27T15:30:00
Solventum Corp Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
Solventum Piper Sandler Healthcare Conference 20242024-12-04T11:30:00
Solventum Corp Third Quarter Earnings Conference Call for 20242024-11-07T16:30:00
Solventum Corp Third Quarter Earnings Result for 20242024-11-07T00:00:00
Morgan Stanley 22nd Annual Global Healthcare Conference2024-09-05T11:30:00
2024 Wells Fargo Healthcare Conference2024-09-04T11:00:00
Solventum Corp Second Quarter Earnings Conference Call for 20242024-08-08T16:30:00
Solventum Corp Second Quarter Earnings Result for 20242024-08-08T00:00:00
Goldman Sachs 45th Annual Global Healthcare Conference 20242024-06-10T20:40:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.